Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Q32 Bio Inc. (QTTB) had Consolidated Net Income/Loss of $57.73M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$57.73M |
|
-- |
|
-- |
|
$7.86M |
|
$-7.86M |
|
$11.85M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
$57.73M |
|
|
Consolidated Net Income/Loss |
$57.73M |
$57.73M |
|
$45.88M |
|
$-7.73M |
|
12.30M |
|
12.31M |
|
$4.70 |
|
$4.70 |
|
| Balance Sheet Financials | |
$55.05M |
|
$0.98M |
|
$6.73M |
|
$61.78M |
|
$11.35M |
|
$3.47M |
|
$8.42M |
|
$19.76M |
|
$42.01M |
|
$42.01M |
|
$42.01M |
|
12.86M |
|
| Cash Flow Statement Financials | |
$-33.54M |
|
$7.00M |
|
$-3.12M |
|
$78.61M |
|
$48.94M |
|
$-29.67M |
|
$5.25M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.85 |
|
-- |
|
-- |
|
0.08 |
|
0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
137.41% |
|
137.41% |
|
93.45% |
|
126.92% |
|
$3.27 |
|
$-2.16 |
|
$-2.72 |
|